Commentary: Litigation over Takeda’s diabetes drug Actos reaches crossroads

Home > News > Missouri Lawyers Weekly > Commentary: Litigation over Takeda’s diabetes drug Actos reaches crossroads

Commentary: Litigation over Takeda’s diabetes drug Actos reaches crossroads

Published: January 16, 2012

Scientific studies and action from the Food and Drug Administration linking diabetes drug Actos to bladder cancer have resulted in lawsuits filed across the country against Actos’ Japanese manufacturer, Takeda. To understand what this body of litigation will look like in 2012 and beyond, it is important to consider what is at stake, what has happened ...

Login required


	User Name/E-mail: Password: Forgot your password

I’m not a subscriber, to which product should I subscribe to read this story?

Use the breadcrumbs at the top of this page to find out in which paper the story appeared. (In the example below, the story appeared in the Kansas City Daily Record.)

If you are already a subscriber to the publication shown in the breadcrumbs, just use the register link under the publications below and you'll be able to log in and read this story. If you are not a subscriber, you can use the subscribe link to gain immediate access.

NOTE: If no publication is listed in the breadcrumb, then the story appeared in Missouri Lawyers Weekly.

Missouri Lawyers Weekly	St Louis Daily Record	The Countian - St Louis	The Countian - Jefferson County	St. Charles County Business Record	Kansas City Daily Record

Subscribe ----- Register ----- Password Reminder	Subscribe ----- Register ----- Password Reminder	Subscribe ----- Register ----- Password Reminder	Subscribe ----- Register ----- Password Reminder	Subscribe ----- Register ----- Password Reminder	Subscribe ----- Register ----- Password Reminder